Schedvins K - Search Results

1

DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.

Carlsten M, Björkström NK, Norell H, Bryceson Y, van Hall T, Baumann BC, Hanson M, Schedvins K, Kiessling R, Ljunggren HG, Malmberg KJ. Carlsten M, et al. Among authors: schedvins k. Cancer Res. 2007 Feb 1;67(3):1317-25. doi: 10.1158/0008-5472.CAN-06-2264. Cancer Res. 2007. PMID: 17283169

2

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.

Malmberg KJ, Levitsky V, Norell H, de Matos CT, Carlsten M, Schedvins K, Rabbani H, Moretta A, Söderström K, Levitskaya J, Kiessling R. Malmberg KJ, et al. Among authors: schedvins k. J Clin Invest. 2002 Nov;110(10):1515-23. doi: 10.1172/JCI15564. J Clin Invest. 2002. PMID: 12438449 Free PMC article.

3

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

Norell H, Carlsten M, Ohlum T, Malmberg KJ, Masucci G, Schedvins K, Altermann W, Handke D, Atkins D, Seliger B, Kiessling R. Norell H, et al. Among authors: schedvins k. Cancer Res. 2006 Jun 15;66(12):6387-94. doi: 10.1158/0008-5472.CAN-06-0029. Cancer Res. 2006. PMID: 16778217

4

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.

Carlsten M, Norell H, Bryceson YT, Poschke I, Schedvins K, Ljunggren HG, Kiessling R, Malmberg KJ. Carlsten M, et al. Among authors: schedvins k. J Immunol. 2009 Oct 15;183(8):4921-30. doi: 10.4049/jimmunol.0901226. J Immunol. 2009. PMID: 19801517

5

Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors.

Alaiya AA, Franzén B, Fujioka K, Moberger B, Schedvins K, Silfversvärd C, Linder S, Auer G. Alaiya AA, et al. Among authors: schedvins k. Int J Cancer. 1997 Nov 27;73(5):678-83. doi: 10.1002/(sici)1097-0215(19971127)73:5<678::aid-ijc11>3.0.co;2-2. Int J Cancer. 1997. PMID: 9398045 Free article.

6

HSP60 predicts survival in advanced serous ovarian cancer.

Hjerpe E, Egyhazi S, Carlson J, Stolt MF, Schedvins K, Johansson H, Shoshan M, Avall-Lundqvist E. Hjerpe E, et al. Among authors: schedvins k. Int J Gynecol Cancer. 2013 Mar;23(3):448-55. doi: 10.1097/IGC.0b013e318284308b. Int J Gynecol Cancer. 2013. PMID: 23429486

7

Protein expression patterns in primary carcinoma of the vagina.

Hellman K, Alaiya AA, Schedvins K, Steinberg W, Hellström AC, Auer G. Hellman K, et al. Among authors: schedvins k. Br J Cancer. 2004 Jul 19;91(2):319-26. doi: 10.1038/sj.bjc.6601944. Br J Cancer. 2004. PMID: 15199389 Free PMC article.

8

Differential tissue-specific protein markers of vaginal carcinoma.

Hellman K, Alaiya AA, Becker S, Lomnytska M, Schedvins K, Steinberg W, Hellström AC, Andersson S, Hellman U, Auer G. Hellman K, et al. Among authors: schedvins k. Br J Cancer. 2009 Apr 21;100(8):1303-14. doi: 10.1038/sj.bjc.6604975. Epub 2009 Mar 24. Br J Cancer. 2009. PMID: 19367286 Free PMC article.

9

Large-scale proteomics analysis of human ovarian cancer for biomarkers.

Bengtsson S, Krogh M, Szigyarto CA, Uhlen M, Schedvins K, Silfverswärd C, Linder S, Auer G, Alaiya A, James P. Bengtsson S, et al. Among authors: schedvins k. J Proteome Res. 2007 Apr;6(4):1440-50. doi: 10.1021/pr060593y. Epub 2007 Feb 22. J Proteome Res. 2007. PMID: 17315909

10

2-DE protein expression in endometrial carcinoma.

Lundgren C, Lahmann J, Becker S, Roblick U, Schedvins K, Boman K, Frankendal B, Nordström B, Auer G. Lundgren C, et al. Among authors: schedvins k. Acta Oncol. 2006;45(6):685-94. doi: 10.1080/02841860600660787. Acta Oncol. 2006. PMID: 16938811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page